Literature DB >> 1673111

Family studies of the LDL receptor gene of relatively severe hereditary hypercholesterolemia associated with Achilles tendon xanthomas.

K Yamakawa1, H Yanagi, K Saku, J Sasaki, T Okafuji, Y Shimakura, K Kawai, S Tsuchiya, K Takada, S Naito.   

Abstract

To assess the relationship between relatively severe hereditary hypercholesterolemia with Achilles tendon xanthomas and the defect of the low density lipoprotein (LDL) receptor gene, family studies were carried out in 17 hypercholesterolemic families. In 16 out of the 17 families, hypercholesterolemia co-segregated with four different gross rearrangements, six different restriction fragment length polymorphism (RFLP) haplotypes, or an abnormal TaqI band of the LDL receptor gene. These findings are compatible with the interpretation that hypercholesterolemia is caused by defective LDL receptor genes, and that the origin of the mutant LDL receptor genes in Japanese generally differs among different pedigrees. In the remaining family, the proband and his sibling, both having relatively severe hypercholesterolemia and Achilles tendon xanthomas, shared an RFLP haplotype, although the proband's other sibling with moderate hypercholesterolemia but without Achilles tendon xanthomas did not. The mutant gene for familial defective apolipoprotein B-100 was not detected in the 17 probands. These data suggest that most, if not all, of the relatively severe hereditary hypercholesterolemia associated with Achilles tendon xanthomas is caused by a defect of the LDL receptor gene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1673111     DOI: 10.1007/bf00194631

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  9 in total

1.  TaqI polymorphism in the LDL receptor gene and a TaqI 1.5-kb band associated with familial hypercholesterolemia.

Authors:  K Yamakawa; T Okafuji; Y Iwamura; K Yuzawa; J Satoh; N Hattori; Y Yamanouchi; H Yanagi; K Kawai; S Tsuchiya
Journal:  Hum Genet       Date:  1988-09       Impact factor: 4.132

2.  Familial defective apolipoprotein B-100: detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases.

Authors:  A Tybjaerg-Hansen; J Gallagher; J Vincent; R Houlston; P Talmud; A M Dunning; M Seed; A Hamsten; S E Humphries; N B Myant
Journal:  Atherosclerosis       Date:  1990-01       Impact factor: 5.162

3.  Radiographic determination of Achilles tendon xanthoma size.

Authors:  D H Blankenhorn; H I Meyers
Journal:  Metabolism       Date:  1969-11       Impact factor: 8.694

4.  Receptor-mediated endocytosis of low-density lipoprotein in cultured cells.

Authors:  J L Goldstein; S K Basu; M S Brown
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

5.  Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100.

Authors:  L F Soria; E H Ludwig; H R Clarke; G L Vega; S M Grundy; B J McCarthy
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

6.  Three novel partial deletions of the low-density lipoprotein (LDL) receptor gene in familial hypercholesterolemia.

Authors:  K Yamakawa; K Takada; H Yanagi; S Tsuchiya; K Kawai; S Nakagawa; G Kajiyama; H Hamaguchi
Journal:  Hum Genet       Date:  1989-07       Impact factor: 4.132

7.  Patterns of polymorphism and linkage disequilibrium suggest independent origins of the human growth hormone gene cluster.

Authors:  A Chakravarti; J A Phillips; K H Mellits; K H Buetow; P H Seeburg
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

8.  Mutations of the low density lipoprotein receptor in Japanese kindreds with familial hypercholesterolemia.

Authors:  T Funahashi; Y Miyake; A Yamamoto; Y Matsuzawa; B Kishino
Journal:  Hum Genet       Date:  1988-06       Impact factor: 4.132

9.  An ultrasonographic method for detection of Achilles tendon xanthomas in familial hypercholesterolemia.

Authors:  K Yuzawa; K Yamakawa; E Tohno; M Seki; M Akisada; H Yanagi; T Okafuji; Y Yamanouchi; N Hattori; K Kawai
Journal:  Atherosclerosis       Date:  1989-02       Impact factor: 5.162

  9 in total
  7 in total

1.  APOE, MTHFR, LDLR and ACE polymorphisms among Angami and Lotha Naga populations of Nagaland, India.

Authors:  Benrithung Murry; Neikethono Vakha; Nongthombam Achoubi; M P Sachdeva; K N Saraswathy
Journal:  J Community Health       Date:  2011-12

2.  Polymorphic haplotypes and recombination rates at the LDL receptor gene locus in subjects with and without familial hypercholesterolemia who are from different populations.

Authors:  A R Miserez; H Schuster; N Chiodetti; U Keller
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

3.  Four new nucleotide sequence polymorphisms in the LDL receptor gene detected by SSCP analysis.

Authors:  K Yamakawa-Kobayashi; T Kobayashi; T Obara; H Hamaguchi
Journal:  Hum Genet       Date:  1993-08       Impact factor: 4.132

4.  Two novel frameshift mutations associated with the presence of direct repeats of the LDL receptor gene in familial hypercholesterolemia.

Authors:  K Yamakawa-Kobayashi; T Kobayashi; K Saku; K Arakawa; H Hamaguchi
Journal:  Hum Genet       Date:  1993-10       Impact factor: 4.132

5.  A novel complex mutation in the LDL receptor gene probably caused by the simultaneous occurrence of deletion and insertion in the same region.

Authors:  K Yamakawa-Kobayashi; T Kobayashi; H Yanagi; Y Shimakura; J Satoh; H Hamaguchi
Journal:  Hum Genet       Date:  1994-06       Impact factor: 4.132

6.  Differential microRNA response to a high-cholesterol, high-fat diet in livers of low and high LDL-C baboons.

Authors:  Genesio M Karere; Jeremy P Glenn; John L VandeBerg; Laura A Cox
Journal:  BMC Genomics       Date:  2012-07-18       Impact factor: 3.969

Review 7.  Is higher serum cholesterol associated with altered tendon structure or tendon pain? A systematic review.

Authors:  Benjamin J Tilley; Jill L Cook; Sean I Docking; James E Gaida
Journal:  Br J Sports Med       Date:  2015-10-15       Impact factor: 13.800

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.